INPROTHER ApS: Financial statements 2014
CVR: 33968426
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
INPROTHER ApS (CVR 33968426) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 33,237 and a net result of DKK 11,373 compared with DKK -104,389 the year before. Equity in the 2014 report amounted to DKK 112,500. The solvency ratio was 86.2%.
- Gross Profit
- DKK 33,237
- Profit/Loss
- DKK 11,373
- Equity
- DKK 112,500
- Total Assets
- DKK 130,500
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 33 t. | 11 t. | 113 t. | - |
| 2013 | - | -60 t. | -104 t. | 101 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
INPROTHER ApS has published its annual report for 2013. Gross profit came to DKK -60,380, and the net result was DKK -104,389.
About INPROTHER ApS
INPROTHER ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Robert M Coleman. The board consists of John Robert M Coleman (chair), Christian Olivier Thirion, Michael Sven Rohmann and Peter Johannes Holst. The company's owners include BIOSTRAT BIOTECH CONSULTING ApS, PETER HOLST CONSULTING ApS and EIC Fund. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK -12,533,972 and a net result of DKK -21,208,923 compared with DKK -8,621,543 the year before. Equity in the 2025 report amounted to DKK 31,798,315.